Clinical trial
Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current…
NCT00003599 · M.D. Anderson Cancer Center, Other · Withdrawn
Key facts
| NCT number | NCT00003599 |
|---|---|
| Title | Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer |
| Official title | A Randomized Study of the Effect of Alpha-tocopherol (AT) on 13-cis-retinoic Acid (13-cRA) Toxicity in a Preliminary Chemoprevention Trial in Former and Current Smokers |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Dietary Supplement, Drug |
| Interventions | Vitamin E (AT), Isotretinoin |
| Enrollment | 0 |
| First posted | Sep 13, 2004 |
| Last update posted | Feb 22, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: